Dual enkephalinase inhibitor (DENKI) PL265: a novel topical treatment for ocular pain ?

Published on May 19, 2017 in Publications

 Download Full Version 

Publications - Latest posts

• PHARMALEADS PRESENTS NEW PUBLICATION IN PAIN IN COLLABORATION WITH “INSTITUT DE LA VISION” IN PARIS, ABOUT THE PHARMACOLOGICAL EFFECTS OF TOPICAL ADMINISTRATION OF PL265 ON OCULAR PAIN
• Substituted α-mercaptoketones, new types of specific neprilysin inhibitors
• Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain
• Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route
• Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain